Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Vnitrni Lekarstvi
|
November 19, 2022
Glomerulonephritides associated with infections
Martin Havrda
Vnitrni Lekarstvi
|
May 17, 2018
[More safe anticoagulant treatment - use of idarucizumab (Praxbind®): case reports from RE-VERSE AD study and clinical practice]
David Tuček, Tomáš Veleta, Martin Havrda
Case Reports in Nephrology and Dialysis
|
November 7, 2018
Bioptically Proven "Anticoagulation-Related Nephropathy" Induced by Dual Antiplatelet Therapy
Karolína Krátká, Martin Havrda, Eva Honsová, et al.
Immunopharmacology and Immunotoxicology
|
May 20, 2017
Clinical case: idelalisib-induced immunoglobulin flare
Jan Novak, Martin Havrda, Lubica Gaherova, et al.
Ceskoslovenska Patologie
|
July 19, 2023
A case report: Acute kidney injury with progression to chronicity in an eldery woman
Olga Snížková, Karolína Krátká, Martin Havrda, et al.
Kidney & Blood Pressure Research
|
January 20, 2022
Can Renal Parameters Predict the Mortality of Hospitalized COVID-19 Patients?
Eli Zolotov, Anat Sigal, Martin Havrda, et al.
Kidney & Blood Pressure Research
|
May 11, 2023
Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality
Eli Zolotov, Anat Sigal, Martin Havrda, et al.
Frontiers in Medicine
|
January 3, 2024
The most common founder pathogenic variant c.868G > A (p.Val290Met) in the <i>NPHS2</i> gene in a representative adult Czech cohort with focal segmental glomerulosclerosis is associated with a milder disease and its underdiagnosis in childhood
Dana Thomasová, Michaela Zelinová, Malgorzata Libik, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Vnitrni Lekarstvi
|
November 19, 2022
Glomerulonephritides associated with infections
Martin Havrda
Vnitrni Lekarstvi
|
May 17, 2018
[More safe anticoagulant treatment - use of idarucizumab (Praxbind®): case reports from RE-VERSE AD study and clinical practice]
David Tuček, Tomáš Veleta, Martin Havrda
Case Reports in Nephrology and Dialysis
|
November 7, 2018
Bioptically Proven "Anticoagulation-Related Nephropathy" Induced by Dual Antiplatelet Therapy
Karolína Krátká, Martin Havrda, Eva Honsová, et al.
Immunopharmacology and Immunotoxicology
|
May 20, 2017
Clinical case: idelalisib-induced immunoglobulin flare
Jan Novak, Martin Havrda, Lubica Gaherova, et al.
Ceskoslovenska Patologie
|
July 19, 2023
A case report: Acute kidney injury with progression to chronicity in an eldery woman
Olga Snížková, Karolína Krátká, Martin Havrda, et al.
Kidney & Blood Pressure Research
|
January 20, 2022
Can Renal Parameters Predict the Mortality of Hospitalized COVID-19 Patients?
Eli Zolotov, Anat Sigal, Martin Havrda, et al.
Kidney & Blood Pressure Research
|
May 11, 2023
Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality
Eli Zolotov, Anat Sigal, Martin Havrda, et al.
Frontiers in Medicine
|
January 3, 2024
The most common founder pathogenic variant c.868G > A (p.Val290Met) in the <i>NPHS2</i> gene in a representative adult Czech cohort with focal segmental glomerulosclerosis is associated with a milder disease and its underdiagnosis in childhood
Dana Thomasová, Michaela Zelinová, Malgorzata Libik, et al.
Page
of 1